Metraipolis › archive › dc_e0f747a342fe

Synthesis and application of quercetin hybrids as potential anticancer agents in the treatment of ovarian cancer — Europe PMC PMID:42050114

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42050114
DOI
10.1038/s41598-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-03T01:09:49.541Z
SHA-256 of the archived text
3871753b81a7d9d51d543a272cd6e1d0013699605f381b95b730099385e3a332
Stable URL of this page
https://metraipolis.com/documento/dc_e0f747a342fe

How to cite

Synthesis and application of quercetin hybrids as potential anticancer agents in the treatment of ovarian cancer — Europe PMC PMID:42050114 — Europe PMC (en), https://europepmc.org/article/MED/42050114 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e0f747a342fe (Metraipolis archive dc_e0f747a342fe, sha256 3871753b81a7d9d51d543a272cd6e1d0013699605f381b95b730099385e3a332)
BibTeX
@misc{dce0f747a342fe,
  title = {Synthesis and application of quercetin hybrids as potential anticancer agents in the treatment of ovarian cancer — Europe PMC PMID:42050114},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42050114},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e0f747a342fe; sha256 3871753b81a7d9d51d543a272cd6e1d0013699605f381b95b730099385e3a332},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42050114. Agents can read the archived copy with the MCP tool read_document.